Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Exicure Inc XCUR

Healthcare Biotechnology
Exicure, Inc. does not have significant operations. Previously, the company focused on developing of nucleic acid therapies targeting ribonucleic acid against validated targets. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:XCUR)

Exicure Presents Positive Topline Phase 2 Data for Burixafor in Multiple Myeloma at 2025 ASH Annual Meeting

GlobeNewswire 4 days ago

Exicure, Inc. Reports Third Quarter 2025 Financial Results

GlobeNewswire November 7, 2025

New Burixafor Clinical Data to be Presented as an Oral Presentation at the 2025 ASH Annual Meeting

GlobeNewswire November 3, 2025

Halper Sadeh LLC Encourages Exicure, Inc. Shareholders to Contact the Firm to Discuss Their Rights

Business Wire October 22, 2025

Exicure Highlights Recent Achievements and Near-term Strategic Priorities

GlobeNewswire October 6, 2025

Exicure, Inc. Reports Second Quarter 2025 Financial Results

Business Wire August 8, 2025

Exicure, Inc. (Nasdaq: XCUR) Regains Compliance with Nasdaq Filing Requirements

Business Wire August 4, 2025

Exicure Completes the Last Patient, Last Visit in Phase 2 Study of GPC-100 for Stem Cell Mobilization in Multiple Myeloma Patients Undergoing Autologous Transplant

Business Wire August 1, 2025

Exicure, Inc. Reports First Quarter 2025 Financial Results

Business Wire June 27, 2025
View More News ››

Opinion & Analysis (NDAQ:XCUR)

Exicure's Collaboration with Allergan on Treating Hair Loss Disorders Sends Shares Higher

Streetwise Reports November 15, 2019
View More Opinion ››

Bullboard Posts (NDAQ:XCUR)

Still holding this stock.

Using the dollar cost averaging method for buying this one and holding it for a while because it will do well all of us shareholders out...
coolfooldumbguy - August 4, 2025

Buy buddy buy.

This stock is a big bargain for people who are buying it at these low prices per share
coolfooldumbguy - March 6, 2025

Using technical analysis for this stock.

It's looking really good for this stock today and you guys should be getting on-board with this one. Wow
coolfooldumbguy - January 17, 2025

XCUR...todays low was $8.43 after ystrdys hi of $14.80

LoL....and the worst is yet to come Wait for it ; )
Iseneschal - November 21, 2024

XCUR...here is a perfect example of how "Share Structure"...

is so relevant to share price appreciation. It boils down to the fact that it doesn't matter what the Company does for it's...
Iseneschal - November 20, 2024

RE:XCUR Just got a buy alert from Tim Skyes Last call DRUG

Well that was timely advice looking back in hindsight and witnessing todays volume & price action!! Trade as high as $14.80 on 15...
Iseneschal - November 20, 2024
View more Bullboard ››

Globex Mining Enterprises Inc.

Globex Mining Enterprises Inc.

Globex Mining Enterprises Inc. engages in the acquisition, exploration, and development of mineral properties in North ...
View More »